Gil Wolfe joins Nils Erik Gilhus to discuss thymectomy in people with MG, with a focus on indications, patient selection, and optimal timing. They reflect on which people with AChR-positive generalized MG are likely to benefit from surgery, how age and disease subtype influence surgical decision-making, and why timing, minimally invasive surgery, and close neurologist–surgeon collaboration are critical to optimizing outcomes.